The analyst price target for DOCS is $74.94, 35% above its fair value estimate. Using the DCF model, the intrinsic value of Doximity, Inc. (NYSE:DOCS) is assessed by forecasting future cash flows and discounting them back to present value.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing